Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.7B | 2.4B | 2.3B | 2.1B |
Cost of revenue | 1.4B | 2.0B | 1.9B | 1.8B |
Gross profit | 296.9M | 431.6M | 443.1M | 382.2M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 131.3M | 161.0M | 152.0M | 131.8M |
Other operating expenses | 5.1M | 6.8M | 5.1M | 6.7M |
Operating income | 160.5M | 263.8M | 286.1M | 243.7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 14.9M | 13.3M | 13.1M | 13.5M |
Other income expense | 7.8M | -17.4M | -19.0M | -1.1M |
Pretax income | 153.4M | 243.3M | 254.0M | 229.2M |
Tax provision | 7.3M | 68.8M | 57.4M | 38.7M |
Net income | 146.1M | 174.5M | 196.6M | 190.4M |
Basic EPS | 0.1 | — | 0.1 | 0.1 |
Diluted EPS | 0.1 | — | 0.1 | 0.1 |
Basic average shares | 1.8B | — | 1.8B | 1.8B |
Diluted average shares | 1.8B | — | 1.8B | 1.8B |
EBITDA | 203.1M | 305.3M | 300.1M | 274.9M |
Net income from continuing op. | 153.4M | 243.3M | 254.0M | 229.2M |
Minority interests | -8.0M | -19.9M | -20.3M | -20.0M |
Preferred stock dividends | — | — | — | — |